Viridian Therapeutics, Inc. (NASDAQ: VRDN) Stock Information | RedChip

Viridian Therapeutics, Inc. (NASDAQ: VRDN)


$22.2100
+0.0400 ( +0.18% ) 126.0K

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

Market Data


Open


$22.2100

Previous close


$22.1700

Volume


126.0K

Market cap


$1.69B

Day range


$21.6660 - $22.3850

52 week range


$11.4000 - $25.3850

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Sep 25, 2023
3 Insider transactions 2 Sep 25, 2023
8-k 8K-related 13 Sep 25, 2023
3 Insider transactions 2 Sep 19, 2023
8-k 8K-related 13 Sep 12, 2023
10-q Quarterly Reports 63 Aug 08, 2023

Latest News